SV1998000146A - Combinaciones de estatina.eter carboxialquilico - Google Patents
Combinaciones de estatina.eter carboxialquilicoInfo
- Publication number
- SV1998000146A SV1998000146A SV1998000146A SV1998000146A SV1998000146A SV 1998000146 A SV1998000146 A SV 1998000146A SV 1998000146 A SV1998000146 A SV 1998000146A SV 1998000146 A SV1998000146 A SV 1998000146A SV 1998000146 A SV1998000146 A SV 1998000146A
- Authority
- SV
- El Salvador
- Prior art keywords
- estatina
- carboxialquilico
- eter
- combinations
- triglycerics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
LA INVENCION SE RELACIONA CON UNA COMBINACION FARMACEUTICA QUE COMPRENDE UN ETER CARBOXILICO QUE REDUCE LOS TRIGLICERICOS Y HDL ELEVADO Y UNA ESTATINA QUE INHIBE LA REDUCTASA HMG-C o A, REDUCIENDO ASI LDL, DICHA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE ENFERMEDADES VASCULARES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6937597P | 1997-12-12 | 1997-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV1998000146A true SV1998000146A (es) | 1999-09-30 |
Family
ID=22088573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV1998000146A SV1998000146A (es) | 1997-12-12 | 1998-12-11 | Combinaciones de estatina.eter carboxialquilico |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP1045691B1 (es) |
JP (1) | JP2002508320A (es) |
KR (1) | KR20010033003A (es) |
AR (1) | AR017851A1 (es) |
AT (1) | ATE285762T1 (es) |
AU (1) | AU754089B2 (es) |
BR (1) | BR9813542A (es) |
CA (1) | CA2304612A1 (es) |
CO (1) | CO4970816A1 (es) |
CR (1) | CR5926A (es) |
CU (1) | CU20000140A7 (es) |
DE (1) | DE69828442T2 (es) |
DK (1) | DK1045691T3 (es) |
ES (1) | ES2230733T3 (es) |
GT (1) | GT199800196A (es) |
HN (1) | HN1998000185A (es) |
HU (1) | HUP0004547A3 (es) |
IL (1) | IL135349A0 (es) |
IS (1) | IS2150B (es) |
MY (1) | MY118381A (es) |
NO (1) | NO20002966D0 (es) |
NZ (1) | NZ503982A (es) |
PA (1) | PA8464601A1 (es) |
PE (1) | PE20000017A1 (es) |
PL (1) | PL341066A1 (es) |
PT (1) | PT1045691E (es) |
SV (1) | SV1998000146A (es) |
UY (1) | UY25299A1 (es) |
WO (1) | WO1999030704A1 (es) |
ZA (1) | ZA9811348B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030105154A1 (en) | 2001-10-24 | 2003-06-05 | Bisgaier Charles Larry | Statin-carboxyalkylether combinations |
US6861555B2 (en) | 2000-01-25 | 2005-03-01 | Warner-Lambert Company | Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
WO1999030706A1 (en) * | 1997-12-12 | 1999-06-24 | Warner-Lambert Company | ANTIHYPERLIPIDEMIC STATIN-LP(a) INHIBITOR COMBINATIONS |
PL346980A1 (en) * | 1998-09-30 | 2002-03-11 | Warner Lambert Co | Method for preventing or delaying catheter-based revascularization |
US6562864B1 (en) * | 1999-09-02 | 2003-05-13 | Drake Larson | Catechin multimers as therapeutic drug delivery agents |
IN191580B (es) * | 1999-12-17 | 2003-12-06 | Ranbaxy Lab Ltd | |
JP4750995B2 (ja) | 2000-01-25 | 2011-08-17 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | カルシウムジカルボキシレートエーテル、その製造法、及びそれを用いた血管系疾患及び糖尿病の治療 |
WO2001078747A1 (de) * | 2000-04-18 | 2001-10-25 | Bayer Aktiengesellschaft | Verwendung von cse-hemmern zur behandlung von herzinsuffizienz |
EA005245B1 (ru) * | 2000-04-26 | 2004-12-30 | Уорнер-Ламберт Компани | Комбинация карбоксиалкиловых эфиров и гипотензивных агентов и фармацевтическое применение |
US6689807B1 (en) * | 2000-06-08 | 2004-02-10 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | HMG CoA reductase inhibitors for promoting angiogenesis |
US6777552B2 (en) | 2001-08-16 | 2004-08-17 | Teva Pharmaceutical Industries, Ltd. | Processes for preparing calcium salt forms of statins |
CA2450820C (en) * | 2001-08-16 | 2011-03-15 | Teva Pharmaceutical Industries Ltd. | Processes for preparing calcium salt forms of statins |
US20050026979A1 (en) * | 2003-07-31 | 2005-02-03 | Maha Ghazzi | Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
EP3735967A1 (en) | 2012-01-06 | 2020-11-11 | NeuroBo Pharmaceuticals, Inc. | Compound for use in methods of reducing risk of cardiovascular disease |
KR20180073665A (ko) | 2015-11-06 | 2018-07-02 | 젬파이어 세러퓨틱스 인코포레이티드 | 심혈관 질환의 치료를 위한 젬카빈 조합 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648387A (en) * | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
-
1998
- 1998-11-12 NZ NZ503982A patent/NZ503982A/en unknown
- 1998-11-20 PT PT98960278T patent/PT1045691E/pt unknown
- 1998-11-20 DE DE69828442T patent/DE69828442T2/de not_active Expired - Lifetime
- 1998-11-20 ES ES98960278T patent/ES2230733T3/es not_active Expired - Lifetime
- 1998-11-20 WO PCT/US1998/024679 patent/WO1999030704A1/en not_active Application Discontinuation
- 1998-11-20 DK DK98960278T patent/DK1045691T3/da active
- 1998-11-20 PL PL98341066A patent/PL341066A1/xx unknown
- 1998-11-20 HU HU0004547A patent/HUP0004547A3/hu unknown
- 1998-11-20 EP EP98960278A patent/EP1045691B1/en not_active Expired - Lifetime
- 1998-11-20 BR BR9813542-2A patent/BR9813542A/pt not_active Application Discontinuation
- 1998-11-20 AU AU15915/99A patent/AU754089B2/en not_active Ceased
- 1998-11-20 IL IL13534998A patent/IL135349A0/xx unknown
- 1998-11-20 JP JP2000538687A patent/JP2002508320A/ja active Pending
- 1998-11-20 AT AT98960278T patent/ATE285762T1/de not_active IP Right Cessation
- 1998-11-20 KR KR1020007006355A patent/KR20010033003A/ko not_active Application Discontinuation
- 1998-11-20 CA CA002304612A patent/CA2304612A1/en not_active Abandoned
- 1998-12-09 HN HN1998000185A patent/HN1998000185A/es unknown
- 1998-12-10 CR CR5926A patent/CR5926A/es not_active Application Discontinuation
- 1998-12-10 ZA ZA9811348A patent/ZA9811348B/xx unknown
- 1998-12-10 MY MYPI98005579A patent/MY118381A/en unknown
- 1998-12-11 AR ARP980106321A patent/AR017851A1/es unknown
- 1998-12-11 SV SV1998000146A patent/SV1998000146A/es not_active Application Discontinuation
- 1998-12-11 PA PA19988464601A patent/PA8464601A1/es unknown
- 1998-12-11 GT GT199800196A patent/GT199800196A/es unknown
- 1998-12-11 CO CO98073828A patent/CO4970816A1/es unknown
- 1998-12-11 PE PE1998001207A patent/PE20000017A1/es not_active Application Discontinuation
- 1998-12-11 UY UY25299A patent/UY25299A1/es not_active Application Discontinuation
-
2000
- 2000-04-14 IS IS5445A patent/IS2150B/is unknown
- 2000-06-09 NO NO20002966A patent/NO20002966D0/no not_active Application Discontinuation
- 2000-06-09 CU CU20000140A patent/CU20000140A7/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV1998000146A (es) | Combinaciones de estatina.eter carboxialquilico | |
ES2178298T3 (es) | Compuestos anti-inflamatorios. | |
EA199900325A1 (ru) | Форма d дигидрата оланзапина | |
GT199800166A (es) | Combinacion de un inhibidor de la aldosa reductasa y un inhibidor de la glucogeno fosforilasa. | |
GT199700009A (es) | Terapia combinada para la osteoporosis. | |
ES2191154T3 (es) | Composicion cosmetica. | |
ES2148345T3 (es) | Composicion farmaceutica con ciclosporina a, un derivado de vitamina e y un emulsionante. | |
SV2002000049A (es) | Uso de inhibidores de cyp2d6 en combinacion con terapias. ref. pc1044 arfw/bb | |
DE69827821D1 (de) | Synergistisch,analgetische zusammensetzung mit opiod-analgetika und zyklooxygenase-2 inhibitoren | |
CO5180587A1 (es) | Composicion farmaceutica de orlistat que contiene tensoactivos y dispersantes | |
HN1998000157A (es) | Agonistas de prostaglandinas | |
ES2152608T3 (es) | Preparacion medicinal que contiene un gas noble lipofilo. | |
BR0112389A (pt) | Pó para condensador | |
CL2004000026A1 (es) | Uso de una composicion que comprende 0 a alrededor de 29% de cis-clomifeno y de alrededor de 100 a alrededor de 71% de trans-clomifeno para preparar un medicamento util para aumentar los niveles de testosterona en suero en un mamifero masculino. | |
ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
BR9811152A (pt) | Composição que compreende própolis e pelo menos um óleo essencial e utilização da mesma | |
ES2155187T3 (es) | Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos. | |
PT1128820E (pt) | Mistura framaceutica compreendendo uma combinacao de profeno e outros compostos activos | |
ECSP982777A (es) | Combinaciones de estatina- - eter carboxialquilico. | |
PA8537101A1 (es) | Antagonistas de receptores de histamina | |
ES2196133T3 (es) | Acelerador de gelificacion, lechada de inyeccion que lo contiene y su uso. | |
SV1999000026A (es) | Combinaciones de estatina-inhibidor de mmp | |
ES2175661T3 (es) | Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
BR9813539A (pt) | Combinações de inibidor de lp(a) e estatina anti-hiperlipidêmicas | |
DOP2001000150A (es) | Agente hipertensivo y su uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant | ||
FD | Lapse |